LH
Labcorp Holdings Inc.
Labcorp Holdings Inc. insider trading
Every time one of LH's executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.
SEC Form 4 data, Q3 2024 to Q2 2026
LH insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 13 insiders traded LH on the open market: 0 purchases and 49 sales worth $34.9M, 24 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 0 purchases and 21 sales ($14.7M), by 9 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | −$1.7M2 sales · all on a plan | |
| Q1 2026 | — | −$5.4M10 sales · 7 on a plan | |
| Q4 2025 | — | −$3.3M2 sales · 1 on a plan | |
| Q3 2025 | — | −$4.3M7 sales · 3 on a plan | |
| Q2 2025 | — | −$2.8M5 sales · 1 on a plan | |
| Q1 2025 | — | −$4.7M9 sales · 6 on a plan | |
| Q4 2024 | — | −$5.9M6 sales · 2 on a plan | |
| Q3 2024 | — | −$6.8M8 sales · 2 on a plan |
- Largest sale
- −$2.8M of LH by Eisenberg Glenn A (Executive Vice President) on Dec 02, 2024.
Open-market transactions through Jun 30, 2026most recent first
Kyle Kathryn W10b5-1
EVP, Chief Legal Officer
−$201.1K
Jun 08, 2026
762 sh · $263.89
Schechter Adam H10b5-1
President & CEO · Director
−$1.5M
May 11, 2026
5,903 sh · $254.50
Wilkinson Peter J10b5-1
SVP, Chief Accounting Officer
−$436.1K
Mar 27, 2026
1,633 sh · $267.05
Meltzer Jonathan C10b5-1
EVP, Operations
−$224.1K
Mar 27, 2026
839 sh · $267.05
Schechter Adam H
President & CEO · Director
−$2.4M
Mar 03, 2026
8,705 sh · $279.96
van der Vaart Sandra D
EVP, Corporate Affairs
−$156K
Feb 27, 2026
548 sh · $284.91
Caveney Brian J
EVP, Pres of ED, CMO & CSO
−$429.5K
Feb 24, 2026
1,500 sh · $286.31
Wilkinson Peter J10b5-1
SVP, Chief Accounting Officer
−$185.1K
Feb 19, 2026
666 sh · $277.94
Meltzer Jonathan C10b5-1
EVP, Operations
−$25.3K
Feb 12, 2026
87 sh · $290.42
Schechter Adam H10b5-1
President & CEO · Director
−$1.5M
Feb 11, 2026
5,273 sh · $284.38
Meltzer Jonathan C10b5-1
EVP, Operations
−$25.2K
Feb 10, 2026
91 sh · $276.79
Meltzer Jonathan C10b5-1
EVP, Operations
−$24.2K
Feb 09, 2026
88 sh · $275.53
Schechter Adam H10b5-1
President & CEO · Director
−$1.5M
Nov 11, 2025
5,745 sh · $262.75
Parham Richelle P
Director
−$1.8M
Oct 31, 2025
7,009 sh · $254.28
van der Vaart Sandra D
EVP, Chief Legal Officer
−$1.1M
Aug 13, 2025
3,903 sh · $271.42
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Jun 08, 2026 | Kyle Kathryn W10b5-1EVP, Chief Legal Officer | 762 | $263.89 | −$201.1K |
| May 11, 2026 | Schechter Adam H10b5-1President & CEO · Director | 5,903 | $254.50 | −$1.5M |
| Mar 27, 2026 | Wilkinson Peter J10b5-1SVP, Chief Accounting Officer | 1,633 | $267.05 | −$436.1K |
| Mar 27, 2026 | Meltzer Jonathan C10b5-1EVP, Operations | 839 | $267.05 | −$224.1K |
| Mar 03, 2026 | Schechter Adam HPresident & CEO · Director | 8,705 | $279.96 | −$2.4M |
| Feb 27, 2026 | van der Vaart Sandra DEVP, Corporate Affairs | 548 | $284.91 | −$156K |
| Feb 24, 2026 | Caveney Brian JEVP, Pres of ED, CMO & CSO | 1,500 | $286.31 | −$429.5K |
| Feb 19, 2026 | Wilkinson Peter J10b5-1SVP, Chief Accounting Officer | 666 | $277.94 | −$185.1K |
| Feb 12, 2026 | Meltzer Jonathan C10b5-1EVP, Operations | 87 | $290.42 | −$25.3K |
| Feb 11, 2026 | Schechter Adam H10b5-1President & CEO · Director | 5,273 | $284.38 | −$1.5M |
| Feb 10, 2026 | Meltzer Jonathan C10b5-1EVP, Operations | 91 | $276.79 | −$25.2K |
| Feb 09, 2026 | Meltzer Jonathan C10b5-1EVP, Operations | 88 | $275.53 | −$24.2K |
| Nov 11, 2025 | Schechter Adam H10b5-1President & CEO · Director | 5,745 | $262.75 | −$1.5M |
| Oct 31, 2025 | Parham Richelle PDirector | 7,009 | $254.28 | −$1.8M |
| Aug 13, 2025 | van der Vaart Sandra DEVP, Chief Legal Officer | 3,903 | $271.42 | −$1.1M |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
After insiders bought LH
What the stock actually did in the 90 days following each open-market purchase
Don't check LH — let it ping you
Get told the moment an insider moves on LH
Pro watches Labcorp Holdings Inc. for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add LH to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.
The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.
How to read LH insider activity
- Open-market purchase (code P)
- An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
- Grants and option exercises (codes A, M)
- Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
- Cluster buy
- Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.
Other Health Care tickers
Questions
- How much LH stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 13 Labcorp Holdings Inc. insiders made no open-market purchases and 49 sales worth $34.9M. 24 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: no purchases and 21 sales ($14.7M). The largest sale was Eisenberg Glenn A selling $2.8M on Dec 02, 2024.
- Where does LH insider trading data come from?
- From the Form 4 filings Labcorp Holdings Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.